Tag Archives: gwph

GW Pharma Drug Impresses At Epilepsy Conference

Biotech GW Pharmaceuticals (GWPH) had investors in a buoyant mood after an epilepsy meeting over the weekend, leading Piper Jaffray to increase its price target and shares to rise 9% to a new high near 105 in early trading in the stock market today. At the first biennial conference of the Dravet Syndrome Foundation, devoted to a particularly severe form of childhood epilepsy, attendees listened to presentations on the efficacy of marijuana-derived

GW Pharma Up On Positive Data For Epilepsy Drug

British biotech GW Pharmaceuticals (GWPH) Tuesday reported positive safety and efficacy data from physicians treating epileptics with its drug Epidiolex, sending the stock up 13% to a new high near 87 in morning trading on the stock market today. In the efficacy group comprising 27 patients, those taking the drug showed a 44% median overall reduction in seizure frequency over 12 weeks, with 22% showing a 90% reduction and 15% having no seizures at